Rubric Capital Management (New York)’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$10.7M Hold
2023
Q4
$6.39M Hold
2023
Q3
$5.67M Hold
2023
Q2
$6.75M Hold
2023
Q1
$6.41M Hold
2022
Q4
$6.61M Buy
2022
Q3
$7.18M Buy
2022
Q2
$3.81M Buy